Fuji Pharma Co., Ltd.
9.75
EUR
-0.25
(-2.50%)
Important Dates
Fuji Pharma Co., Ltd.'s next confirmed earnings release is scheduled for November 10, 2026.
| Earnings Date | 11/10/2026 |
Share Statistics
As of March 31, 2026, Fuji Pharma Co., Ltd. has 26.12M shares outstanding.
| Shares Outstanding | 26.12M |
Financial Position
As of March 31, 2026, Fuji Pharma Co., Ltd. maintains a current ratio of 1.68, meaning it holds 1.7x the short-term assets needed to cover near-term liabilities.
| Current Ratio | 1.68 |
| Quick Ratio | 0.34 |
| Debt / Equity | 57.66 |
Financial Efficiency
These figures cover the twelve months ended March 31, 2026.
| Employee Count | 1,734.50 |
Balance Sheet
EURAs of March 31, 2026, Fuji Pharma Co., Ltd. holds 59.35M in cash and equivalents against 161.46M in total debt, resulting in a net debt position of 78.04M. Total book value stands at 279.98M, with working capital of 120.05M providing operational flexibility.
| Cash & Cash Equivalents | 59.35M |
| Total Debt | 161.46M |
| Net Debt | 78.04M |
| Equity (Book Value) | 279.98M |
| Book Value Per Share | 10.72 |
| Working Capital | 120.05M |
Stock Splits
Fuji Pharma Co., Ltd.'s most recent stock split took place on June 27, 2018 with a 1:2 split ratio.
| Last Split Date | 6/27/2018 |
| Split Ratio | 1:2 |